Start here if you're new
what it is
CACI sells tech, intelligence tools, and mission support to the Pentagon and other federal agencies.
how it gets paid
Last year L made $8.6B in revenue. Department of Defense was the main engine at $6.45B, or 75% of sales.
why it's growing
Revenue grew 12.6% last year. The 29.71% EPS beat matters most because it tells you demand held up better than analysts expected.
what just happened
CACI's last reported quarter beat estimates by 29.71%, with EPS of $6.81 versus a $5.25 consensus.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
85/100 earnings predictability — you can trust these numbers
27.4x trailing p/e — priced about right
10.0% return on capital — nothing to write home about
xvary composite: 70/100 — average
What they do
CACI sells tech, intelligence tools, and mission support to the Pentagon and other federal agencies.
CACI wins because government work is sticky. Security clearances and mission software are switching costs (hard-to-remove embedded tools) — so what: once your system is inside a sensitive program, replacing it is painful. That helps CACI keep 75% of revenue tied to the Department of Defense on $8.6 billion in annual sales.
How they make money
$8.6B
annual revenue · their business grew +12.6% last year
Department of Defense
$6.45B
Federal Civilian Agencies
$1.72B
Commercial
$0.22B
Other
$0.21B
The products that matter
serves federal agencies
Government technology and mission services
$8.6B revenue · 100% of sales
it's the entire business. Revenue reached $8.6B and grew 12.6% last year, so every growth argument on this stock is really a contract pipeline argument.
entire business
Key numbers
14.5%
eps growth
Projected earnings growth is 14.5% a year. Plain English: profit is still expected to rise faster than revenue, which helps justify paying up for the stock.
27.4x
trailing p/e
Trailing P/E (price-to-earnings ratio) → how many dollars investors pay for $1 of past profit → so what: you are paying a premium for steady government growth.
10.0%
return on capital
Return on capital → profit earned on money put into the business → so what: CACI is solid, but not absurdly efficient for a company priced like a premium asset.
$2.9B
long-term debt
Debt is 18% of capital, which is manageable. Plain English: the balance sheet is carrying weight, but not enough to run the story.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 70 / 100
- long-term debt $2.9B (18% of capital)
- net profit margin 5.5% — keeps 6 cents of every dollar in revenue
- return on equity 14% — $0.14 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in CACI 3 years ago → it's now worth $20,160.
The index would have given you $13,880.
source: institutional data · total return
What just happened
beat estimates
CACI's last reported quarter beat estimates by 29.71%, with EPS of $6.81 versus a $5.25 consensus.
Quarterly EPS history shows fiscal 2026 second-quarter EPS at $6.81, up from $4.88 in the prior year period. EDGAR also shows the latest quarter's revenue at $4.5B, up 103% vs. prior year, which is the kind of number that makes future comparisons rude.
$2.1B
revenue
$6.81
eps
29.71%
surprise
the number that mattered
The 29.71% EPS beat matters most because it tells you demand held up better than analysts expected, even after the stock's run.
-
caci international is expanding into space.in late december, management announced the acquisition of arka group from private equity firm blackstone. the purchase will extend caci's electronic sensing and actionable intelligence offerings to outer space. the $2.6 billion all-cash deal is expected to close in the third quarter, after all regulatory requirements are met. as is our convention, the affect of the deal is excluded from our financial presentation until it is finalized. arka's capabilities will complement caci's electronic warfare business, which today generates about a $2 billion in annual revenue. the firm has been very successful winning new contracts with drone detection partnership with anduril.
-
in addition to domestic contracts, international interest and demand is strong.
-
with its solid reputation for sensing and monitoring, in the december quarter, caci was an awardee as part of a group for the massive multi-year $151 billion missile defense agency's shield program to provide protection against air, missile, space, and cyber threats.
-
recent fiscal second-quarter earnings results (year ends june 30th) were stronger than expected.
-
revenues increased about 6% and earnings advanced almost 15% on a like-for-like basis.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is federal budget delays or procurement slowdowns.
med
Washington is the customer
100% of CACI's $8.6B revenue comes from government work. If awards slip, budgets freeze, or priorities move, the whole business feels it.
This is not a segment issue. It is full top-line exposure.
med
6.4% margins leave less room for mistakes
CACI is profitable, but it is still a contractor. A few lower-margin wins, cost overruns, or integration hiccups matter more here than they would in a software business.
When your net margin is 6.4%, small misses can do outsized damage to EPS.
med
the stock already assumes competence
A 27.4x trailing p/e and a 52-week range up to $684 tell you investors have rewarded execution. That cuts both ways if growth cools toward the quarterly 6% pace.
This is the kind of setup where a decent quarter can be fine and a merely okay one can hurt.
all three risks point to the same place: 100% of CACI's $8.6B revenue depends on public-sector demand, and a 6.4% margin profile gives you less cushion than the stock's quality reputation implies.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
revenue growth after a +12.6% year
The full year was strong. The latest quarter grew 6%. If that gap persists, the market will notice.
risk
budget timing and award flow
When one customer drives 100% of revenue, procurement delays stop being background noise.
earnings
next quarter's margin discipline
With a 6.4% net margin, you want the next report to show the recent EPS strength was not just one clean quarter.
trend
whether the stock can earn the $709 midpoint
That target implies about 16% upside from $612.37. The business needs continued contract execution to get there.
Analyst rankings
short-term outlook
top 20%
momentum score 2 — analysts expect above-average price performance in the year ahead. in human-speak: they still like the setup.
risk profile
average
stability score 3 — typical stock risk. Not fragile, not a bunker.
chart momentum
average
technical score 3 — the chart is not giving you a dramatic signal either way.
earnings predictability
85 / 100
management usually lands near expectations. You are not signing up for biotech-style surprises.
source: institutional data
Institutional activity
institutions have been net buying for 2 consecutive quarters — 276 buyers vs. 274 sellers in 3q2025. total institutional holdings: 21.7M shares. net buying for 2 quarters.
source: institutional data
Price targets
3-5 year target range
$444
$974
$612
current price
$709
target midpoint · +16% from current · 3-5yr high: $1030 (+70% · 14% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive